Home Newsfeeds Oppenheimer Initiates Coverage On Host Hotels & Resorts with Perform Rating, Announces Price Target of $21

Oppenheimer Initiates Coverage On Host Hotels & Resorts with Perform Rating, Announces Price Target of $21

Oppenheimer analyst Tyler Batory initiates coverage on Host Hotels & Resorts (NASDAQ:HST) with a Perform rating and announces Price Target of $21.

byBenzinga Newsdesk

September 15, 2022

1 minute read

Oppenheimer analyst Tyler Batory initiates coverage on Host Hotels & Resorts (NASDAQ:HST) with a Perform rating and announces Price Target of $21.

Analyst Ratings

A Glimpse Into The Expert Outlook On Nike Through 29 Analysts

By Benzinga Insights

April 30, 12:00 PM

Analysts’ ratings for Nike (NYSE:NKE) over the last quarter vary from bullish to bearish, as provided by 29…

NKE

Analyst Ratings

Where Nuvei Stands With Analysts

By Benzinga Insights

Today, 12:01 PM

Analysts have provided the following ratings for Nuvei (NASDAQ:NVEI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

NVEI

AMD Faces New Challenge as China Advances with RISC-V Chip Technology

By Anusuya Lahiri

February 5, 9:32 AM

AMD & Intel dominate x86 chip market, but China's push for RISC-V architecture challenges their dominance and reshapes chip industry.

AMD

Why Is Rare Muscle Disease-Focused Dyne Therapeutics Stock Soaring Today?

By Vandana Singh

January 3, 9:07 AM

Dyne Therapeutics Inc (NASDAQ: DYN) released initial clinical data from its ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1) and its DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD)

DYN

Oppenheimer Initiates Coverage On Host Hotels & Resorts with Perform Rating, Announces Price Target of $21

Related Posts

A Glimpse Into The Expert Outlook On Nike Through 29 Analysts

Where Nuvei Stands With Analysts

AMD Faces New Challenge as China Advances with RISC-V Chip Technology

Why Is Rare Muscle Disease-Focused Dyne Therapeutics Stock Soaring Today?